Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00301379 · ClinicalTrials.gov registry record
Registry Study of Neoadjuvant Chemoradiation & Transplant for Cholangiocarcinoma Patients
A clinical trial, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- 59
- Enrollment target
NCT00301379: Clinical Trial study, sponsored by Washington University School of Medicine.
NCT00301379 is a clinical trial that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 59 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00301379 was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- 59 participants
- Enrollment target
Study Summary
This is an observational study intended to validate results of a previous study done at the Mayo Clinic. Patients are treated with combination chemotherapy and radiation and maintained on oral Xeloda until they can receive liver transplant. A staging laparotomy is performed before chemoradiation in order to identify patients who will most benefit from the treatment and to improve outcomes.
Interventions
- OTHER Observation data collection study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2005-08-12 |
| Est. Completion | 2023-06-06 |
Why NCT00301379 stopped before completion
NCT00301379 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 59 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Observation data collection study. is the first listed.
NCT00301379 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00301379 about?
NCT00301379 is a clinical study titled "Registry Study of Neoadjuvant Chemoradiation & Transplant for Cholangiocarcinoma Patients". This is an observational study intended to validate results of a previous study done at the Mayo Clinic. Patients are treated with combination chemotherapy and radiation and maintained on oral Xeloda until they can receive liver transplant. A staging laparotomy is performed before chemoradiation in ...
What is the current status of trial NCT00301379?
This trial is currently terminated. The enrollment target is 59 participants. The study started on 2005-08-12. Estimated completion is 2023-06-06.
What interventions are being tested in trial NCT00301379?
The interventions under investigation include: Observation data collection study. (OTHER).
Who is sponsoring clinical trial NCT00301379?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI